- #IRAPP LICENSE UPDATE#
- #IRAPP LICENSE FULL#
- #IRAPP LICENSE SOFTWARE#
- #IRAPP LICENSE PC#
- #IRAPP LICENSE LICENSE#
Accordingly, we were not required to pay any license royalties to Microsoft in 2014 or 2015.
#IRAPP LICENSE SOFTWARE#
In consideration for the Microsoft license, we paid Microsoft an initial royalty of $10,000 in 2009 and are required to pay additional royalties to Microsoft based on the extent to which our iRAPP software products implement Microsoft protocols however, our software products do not require the implementation of Microsoft protocols. Pursuant to the Microsoft license, we have been granted a worldwide, non-exclusive license to use Microsoft client-server software communications protocols in the development of our software to facilitate inter-operation or communication between our software and Windows server and client software. Users gain the ability to integrate Mac software into a Windows based IT infrastructure, allowing users to develop OS X/iOS applications, access remote documents, run shared business applications, perform quality assurance functions and control and maintain servers and personal computers remotely. iRAPP is an authorized licensee of the Microsoft RDP, allowing iRAPP users to access the system with any RDP compliant device.
#IRAPP LICENSE PC#
The iRAPP user interface yields a seamless user experience allowing the user to remotely access specific Mac applications within the PC desktop environment in a cohesive manner.
Instead of the siloed “desktop-within-a-desktop” interface, iRAPP provides an interactive and merged environment between PC and Mac work spaces, without additional hardware, training or orientation. We developed the iRAPP protocol to overcome the disjointed user experience offered by conventional remote access technology. Completion of the Merger is contingent upon the satisfaction of certain closing conditions, including customary due diligence considerations, the negotiation, execution and delivery of a merger agreement by the parties, and board and approval of the stockholders of both Aegis and the Company. If the Merger is not consummated, the Promissory Note, including accrued interest, is due and payable on June 30, 2016, or upon certain other events as specified in the Promissory Note.
#IRAPP LICENSE FULL#
The obligations under the Promissory Note will be discharged in full if the Merger is consummated. Aegis previously issued a Promissory Note (as defined below) to the Company to evidence the receipt of a loan from the Company, the proceeds of which are expected to be used by Aegis for general working capital purposes, including the payment of expenses related to the Merger. The obligations of the parties to consummate the Merger are not subject to any financing condition. While it is currently anticipated that the Merger will be completed in the second quarter of 2016, there can be no assurance that such conditions will be satisfied in a timely manner or at all, or that an effect, event, development or change will not transpire that could delay or prevent these conditions from being satisfied. The completion of the Merger is subject to certain conditions, including, among others, the receipt of the approval of the Merger and adoption of the Merger Agreement by the affirmative vote of the holders of a majority of shares of the Company’s common stock outstanding and entitled to vote.
#IRAPP LICENSE UPDATE#
We do not undertake any obligation to update or revise any forward-looking statements. You are cautioned to not place undue reliance on these forward-looking statements, which speak only as of their dates. These forward-looking statements are not guarantees of future performance. In light of these numerous risks and uncertainties, we cannot provide any assurance that the results and events contemplated by our forward-looking statements contained in this Annual Report on Form 10-K will in fact transpire. As a result, the identification and interpretation of data and other information and their use in developing and selecting assumptions from and among reasonable alternatives require the exercise of judgment. Our assumptions used for the purposes of the forward-looking statements specified in the following information represent estimates of future events and are subject to uncertainty as to possible changes in economic, legislative, industry, and other circumstances, including the development, acceptance and sales of our products and our ability to raise additional funding sufficient to implement our strategy. For a discussion of these risks, you should read this entire Annual Report on Form 10-K carefully, especially the risks discussed under the section entitled “Risk Factors” Although we believe that our assumptions underlying such forward-looking statements are reasonable, we do not guarantee our future performance, and our actual results may differ materially from those contemplated by these forward-looking statements.
0 kommentar(er)
